ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 102 filers reported holding ASCENDIS PHARMA A/S in Q2 2018. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $48,959,306 | -9.8% | 417,172 | +3.3% | 3.76% | +8.4% |
| Q4 2021 | $54,306,801 | -23.5% | 403,678 | -9.3% | 3.47% | -29.6% |
| Q3 2021 | $70,960,906 | +123.1% | 445,203 | +84.1% | 4.93% | +132.4% |
| Q2 2021 | $31,805,370 | -20.9% | 241,774 | -22.5% | 2.12% | -29.8% |
| Q1 2021 | $40,193,419 | +28.8% | 311,867 | +66.7% | 3.02% | -17.4% |
| Q4 2020 | $31,195,032 | +25.6% | 187,043 | +16.2% | 3.66% | -33.7% |
| Q3 2020 | $24,846,137 | -23.8% | 161,004 | -26.9% | 5.52% | +23.5% |
| Q2 2020 | $32,588,878 | +5.0% | 220,344 | -20.0% | 4.47% | -42.1% |
| Q1 2020 | $31,023,379 | +9.9% | 275,494 | +35.8% | 7.71% | +54.7% |
| Q4 2019 | $28,226,613 | +24.0% | 202,894 | -14.2% | 4.98% | -29.4% |
| Q3 2019 | $22,769,277 | +45.0% | 236,392 | +73.3% | 7.06% | +60.6% |
| Q2 2019 | $15,706,115 | +29.2% | 136,397 | +32.0% | 4.40% | +24.0% |
| Q1 2019 | $12,157,939 | +1172.2% | 103,296 | +577.2% | 3.55% | +586.1% |
| Q4 2018 | $955,663 | -29.2% | 15,254 | -19.9% | 0.52% | -12.8% |
| Q3 2018 | $1,350,166 | -32.5% | 19,054 | -36.6% | 0.59% | -35.1% |
| Q2 2018 | $1,999,192 | +27.1% | 30,054 | +24.9% | 0.91% | +25.0% |
| Q1 2018 | $1,573,132 | +224.1% | 24,054 | +98.5% | 0.73% | +162.0% |
| Q4 2017 | $485,447 | – | 12,118 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 133,691 | $13,805,000 | 36.44% |
| RA Capital Management | 7,567,900 | $781,462,000 | 16.67% |
| Q Global Advisors, LLC | 145,209 | $16,699,000 | 11.49% |
| BERYLSON CAPITAL PARTNERS, LLC | 51,000 | $5,266,000 | 8.70% |
| Spyglass Capital Management LLC | 949,915 | $98,088,000 | 6.94% |
| Paradigm Biocapital Advisors LP | 497,347 | $51,356,000 | 6.85% |
| Avoro Capital Advisors LLC | 2,850,000 | $294,291,000 | 5.44% |
| Deep Track Capital, LP | 1,000,000 | $103,260,000 | 4.73% |
| Finepoint Capital LP | 123,400 | $12,742,000 | 4.19% |
| Deep Track Capital, LP | 800,000 | $82,608,000 | 3.78% |